Cargando…
ODP560 Thyroid Hormones membrane receptor, Integrin αvβ3, as a potential prognostic marker of chemotherapy response in breast cancer
Despite the development of novel therapies, breast cancer (BC) tumors are treated with conventional therapy eventually. Due to tumor heterogeneity, it is necessary to define new biomarkers to identify groups with different molecular characteristic and on this basis improve the treatment decision. Th...
Autores principales: | Haedo, Mateo Campos, Florencia Cayrol, M, Cremaschi, Graciela, Mercedes Debernardi, M, Albuja, Johanna Diaz, Albuja, M Celeste Díaz, Alejandra Paulazo, M, Rosemblit, Cinthia, Sterle, Helena |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9627778/ http://dx.doi.org/10.1210/jendso/bvac150.1813 |
Ejemplares similares
-
SUN-LB054 Cilengitide Reverts Thyroid Hormones Effects in Bexarotene Treatment of Breast Cancer Cells
por: Díaz Albuja, Johanna, et al.
Publicado: (2019) -
Thyroid hormones induce doxorubicin chemosensitivity through enzymes involved in chemotherapy metabolism in lymphoma T cells
por: Díaz Flaqué, María Celeste, et al.
Publicado: (2019) -
Non-genomic Actions of Thyroid Hormones Regulate the Growth and Angiogenesis of T Cell Lymphomas
por: Cayrol, Florencia, et al.
Publicado: (2019) -
Editorial: Hormones and receptors in breast cancer
por: Rosemblit, Cinthia, et al.
Publicado: (2023) -
ODP540 Aromatase interacting partner in Breast (AIPB) regulates estradiol in human breast
por: Moffitt, Alyssa M, et al.
Publicado: (2022)